Kinetic Control of Amyloidogenesis Calls for Unconventional Drugs To Fight Alzheimer's Disease

ACS Chem Neurosci. 2020 Jan 15;11(2):103-104. doi: 10.1021/acschemneuro.9b00676. Epub 2020 Jan 6.

Abstract

Computer simulations had predicted that amyloid fibrillogenesis is governed by free energy barriers and kinetic traps (kinetic control), rather than the free energy of the final aggregates. The simulations suggested that the diversity in fibril morphologies can originate from variations in the number of protofilaments which has been confirmed by recent cryo-electron microscopy studies of amyloid-β fibrils derived from brain tissue of Alzheimer's patients. The kinetic control of fibril formation and polymorphism imply that chemical substances with new mechanisms of action are needed to fight Alzheimer's disease.

Keywords: Alzheimer’s disease; Amyloidogenesis; coarse-grained simulations; fibrillogenesis; molecular dynamics.

MeSH terms

  • Alzheimer Disease / pathology*
  • Amyloid / chemistry*
  • Computer Simulation*
  • Humans
  • Kinetics
  • Models, Molecular
  • Protein Aggregation, Pathological* / pathology
  • Protein Conformation

Substances

  • Amyloid